# Pulmonary hypertension: etiology and anti-inflammatory treatment pathways of natural products

**Authors:** Liyang Li, Xing Huang, Maojun Cheng, Chengxun He, Changmao Dai, Fang Ding, Jia Xu, Feier Chen, Kaichen Zhang, Xueping Li

PMC · DOI: 10.3389/fphar.2025.1743782 · Frontiers in Pharmacology · 2026-01-26

## TL;DR

This paper reviews how natural products can help treat pulmonary hypertension by targeting inflammation and vascular changes.

## Contribution

The paper highlights novel therapeutic strategies using natural products to modulate inflammation in pulmonary hypertension.

## Key findings

- Natural products show potential in modulating pulmonary vascular remodeling.
- Inflammation plays a crucial role in the progression of pulmonary hypertension.
- Natural products offer a safe and cost-effective alternative to current therapies.

## Abstract

Pulmonary hypertension (PH) is a severe and progressive cardiopulmonary disorder that affects multiple organ systems. Clinically, it is manifested by progressive dyspnea, which progressively worsens with exertion and ultimately results in right heart failure and death at a late stage. Its pathological features are primarily characterized by abnormally elevated pulmonary artery pressure, pulmonary vascular remodeling, and thrombus formation. The inflammatory response is widely recognized as a key initiating factor and critical component in the progression of PH. Furthermore, therapeutic interventions are hampered by the irreversibility of vascular remodeling, high treatment expense, and hepatotoxicity induced by pharmacologic agents. Therefore, it is of great importance and potential to develop novel therapies with multi-targeted, safe, efficacious, and low-cost characteristics. Emerging evidence has demonstrated that natural products (NPs) possess remarkable potential in modulating pulmonary vascular remodeling (PVR) and right ventricular function, and their effects may be associated with inflammation. In this review, we comprehensively review recent advances in the use of NPs to ameliorate PH by modulating inflammation-associated signaling pathways, highlighting the crucial role of inflammation in PH pathogenesis. We attempt to provide a theoretical basis and research strategy for using inflammatory approaches with natural products in PH, which would be helpful for the development of novel therapies.

## Linked entities

- **Diseases:** pulmonary hypertension (MONDO:0005149)

## Full-text entities

- **Diseases:** inflammation (MESH:D007249), PH (MESH:D006976), right heart failure (MESH:D006333), death (MESH:D003643), cardiopulmonary disorder (MESH:D006323), thrombus (MESH:D013927), dyspnea (MESH:D004417)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12883753/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12883753/full.md

## References

204 references — full list in the complete paper: https://tomesphere.com/paper/PMC12883753/full.md

---
Source: https://tomesphere.com/paper/PMC12883753